trending Market Intelligence /marketintelligence/en/news-insights/trending/2lp2dfxyuctly_4xfl7atw2 content esgSubNav
In This List

Easton Pharmaceuticals adds board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Easton Pharmaceuticals adds board member

Easton Pharmaceuticals Inc. appointed Daniel Bagi to its board.

Bagi will also be president of business development.

He recently helped the company and its Latin American joint venture partner BMV Medica SA de CV secure a sub-licensing deal with with Bayer AG for VS-Sense, a bacterial vaginosis diagnostic product, for Mexico.